Clinical Trials in Nashville

Showing 2021-2040 of 9,711 trials

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

This is a 2-part study. In Part 1, participants will be dosed at 2 different dose levels in order to select the RP2D for Part 2 of the study.

MyelofibrosisPolycythemia VeraThrombocythemia

Incyte Corporation4 participantsStarted Jul 2021

New Orleans, Louisiana, United States • Bethesda, Maryland, United States • Kansas City, Missouri, United States +18 more locations

COMPLETEDPhase 3< 1 mile

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

NCT04167514

Study CSL964\_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with high-risk acute GVHD

Graft Versus Host Disease (GVHD)

CSL Behring136 participantsStarted Jan 2020

Stanford, California, United States • Gainesville, Florida, United States • Tampa, Florida, United States +22 more locations

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Find Trials by Condition in Nashville

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

A Study of LY3549492 in Healthy Weight Adult Participants

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Symptom Management Implementation of Patient Reported Outcomes in Oncology

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

MR Image Synthesis With Low Gadobutrol Dose and AI

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)